Naci Çil
Research Subjects
Naci Çil has a total of 357 co-authors. Here are the top co-authors by number of shared publications:
- Çınar Yıldırım2 shared publications
- Özgür Sirkeci
Department of Internal Medicine, Division of Gastroenterology, Isparta City Hospital, 32200 Isparta, Turkey
2 shared publications - Abdullah İlHan
University of Health Sciences Adana City Training and Research Hospital, Department of Gastroenterology, Adana, Türkiye
1 shared publication - Abdullah Mubin Özercan
Department of Gastroenterology, Fırat University, Elazig 23119, Türkiye
1 shared publication - Abdullah Murat Buyruk1 shared publication
- Abdullah Tokuç
Üniversitesi Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi Gastroenteroloji Kliniği
1 shared publication
Latest Publications
- Open Access
Effects of BMI and Anticoagulant/Antiplatelet Therapy on the Severity of Gastrointestinal Bleeding
Background and Objectives: Obesity is a major global public health problem associated with numerous complications. Likewise, the use of antiplatelet and anticoagulant agents has increased with population aging and the growing burden of cardiovascular diseases. This study aimed to evaluate the effects of obesity and antiplatelet/anticoagulant therapy on the clinical presentation, bleeding severity, and short-term clinical outcomes of patients with gastrointestinal bleeding. Materials and Methods: A prospective cohort study was conducted in consecutive patients admitted with upper or lower gastrointestinal bleeding to a tertiary referral center between January 2024 and January 2025. Patients were categorized according to body mass index (BMI) and antithrombotic therapy status. Clinical characteristics, bleeding severity scores, treatment requirements, and short-term clinical outcomes were compared. Multivariable multinomial logistic regression analysis was performed to identify independent associations. Results: A total of 177 patients were included. Obese and overweight patients were significantly older than normal-weight patients (p = 0.001), whereas no significant differences were observed among BMI groups regarding the Glasgow–Blatchford score, pre-endoscopic Rockall score, transfusion requirements, endoscopic intervention, or short-term clinical outcomes. Patients receiving antiplatelet or anticoagulant therapy had significantly higher Charlson Comorbidity Index, bleeding severity scores, and packed red blood cell transfusion requirements than those receiving no antithrombotic therapy (all p < 0.01). However, after multivariable adjustment, these associations did not remain independent, and advanced age remained the only independent factor common to both treatment groups. Conclusions: Obesity was not independently associated with bleeding severity or short-term clinical outcomes in patients with gastrointestinal bleeding. Although antiplatelet and anticoagulant therapy were associated with more severe bleeding-related clinical findings, these associations were not independent after multivariable adjustment.
Open AccessEffects of BMI and Anticoagulant/Antiplatelet Therapy on the Severity of Gastrointestinal Bleeding
Background and Objectives: Obesity is a major global public health problem associated with numerous complications. Likewise, the use of antiplatelet and anticoagulant agents has increased with population aging and the growing burden of cardiovascular diseases. This study aimed to evaluate the effects of obesity and antiplatelet/anticoagulant therapy on the clinical presentation, bleeding severity, and short-term clinical outcomes of patients with gastrointestinal bleeding. Materials and Methods: A prospective cohort study was conducted in consecutive patients admitted with upper or lower gastrointestinal bleeding to a tertiary referral center between January 2024 and January 2025. Patients were categorized according to body mass index (BMI) and antithrombotic therapy status. Clinical characteristics, bleeding severity scores, treatment requirements, and short-term clinical outcomes were compared. Multivariable multinomial logistic regression analysis was performed to identify independent associations. Results: A total of 177 patients were included. Obese and overweight patients were significantly older than normal-weight patients (p = 0.001), whereas no significant differences were observed among BMI groups regarding the Glasgow–Blatchford score, pre-endoscopic Rockall score, transfusion requirements, endoscopic intervention, or short-term clinical outcomes. Patients receiving antiplatelet or anticoagulant therapy had significantly higher Charlson Comorbidity Index, bleeding severity scores, and packed red blood cell transfusion requirements than those receiving no antithrombotic therapy (all p < 0.01). However, after multivariable adjustment, these associations did not remain independent, and advanced age remained the only independent factor common to both treatment groups. Conclusions: Obesity was not independently associated with bleeding severity or short-term clinical outcomes in patients with gastrointestinal bleeding. Although antiplatelet and anticoagulant therapy were associated with more severe bleeding-related clinical findings, these associations were not independent after multivariable adjustment.
- Open Access
- 17 September 2025
- Published by Academician Publishing
Gastroenteroloji Textbook - Cilt (1-2)
- 17 September 2025
- Published by Academician Publishing
Open AccessGastroenteroloji Textbook - Cilt (1-2)
- Open Access
- 17 September 2025
- Published by Academician Publishing
- p. 381-396
Gastrik Vasküler Hastalıklar
Gastrik vasküler hastalıklar, gastrointestinal kanamaya sebep olmaları açısından önemlidir. Tekrarlayan kanama eğilimleri ve yaşamı tehdit eden kan kaybına yol açma potansiyelleri nedeniyle gastrik vasküler anormallikler, ciddi morbidite ve maliyete neden olurlar. Gastrik vasküler lezyonların tıbbi ve endoskopik tedavisinde her geçen gün ilerlemeler olmaktadır. Yeni veriler, gastrik antral vasküler ektazi (GAVE) tedavisinde endoskopik bant ligasyonu ve ablasyonun, argon plazma koagülasyon (APK) ile karşılaştırılabilir hatta daha üstün olabileceğini düşündürmektedir. Anjiyodisplazilerin tespiti için video kapsül endoskopilerin okunmasını kolaylaştırmak amacıyla son derece hassas bilgisayar destekli sistemler geliştirilmiş, yapay zekadan faydalanılmasının önü açılmıştır. OTS klipsleme, Dieulafoy lezyonlarına bağlı kanamanın kontrolünde ümitlendirici sonuçlar veren nispeten yeni bir teknolojidir. Bu bölümde, sık görülen gastrik vasküler lezyonların tanı ve tedavisi gözden geçirilecektir.
- 17 September 2025
- Published by Academician Publishing
- p. 381-396
Open AccessGastrik Vasküler Hastalıklar
Gastrik vasküler hastalıklar, gastrointestinal kanamaya sebep olmaları açısından önemlidir. Tekrarlayan kanama eğilimleri ve yaşamı tehdit eden kan kaybına yol açma potansiyelleri nedeniyle gastrik vasküler anormallikler, ciddi morbidite ve maliyete neden olurlar. Gastrik vasküler lezyonların tıbbi ve endoskopik tedavisinde her geçen gün ilerlemeler olmaktadır. Yeni veriler, gastrik antral vasküler ektazi (GAVE) tedavisinde endoskopik bant ligasyonu ve ablasyonun, argon plazma koagülasyon (APK) ile karşılaştırılabilir hatta daha üstün olabileceğini düşündürmektedir. Anjiyodisplazilerin tespiti için video kapsül endoskopilerin okunmasını kolaylaştırmak amacıyla son derece hassas bilgisayar destekli sistemler geliştirilmiş, yapay zekadan faydalanılmasının önü açılmıştır. OTS klipsleme, Dieulafoy lezyonlarına bağlı kanamanın kontrolünde ümitlendirici sonuçlar veren nispeten yeni bir teknolojidir. Bu bölümde, sık görülen gastrik vasküler lezyonların tanı ve tedavisi gözden geçirilecektir.